As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

New York, New York-- (Newsfile Corp. - February 10, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ...

New York, New York-- (Newsfile Corp. - February 9, 2025) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ...

The FDA granted breakthrough status to Serial CTRS, an AI tool that improves survival predictions in non–small cell lung ...

Onc.AI receives US FDA’s breakthrough device designation for its serial CT response score deep learning model: San Carlos, California Saturday, February 8, 2025, 16:00 Hrs [IST] ...

FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

The Clinical Trials Market report delivers crucial insights into the ... this report acts as a strategic tool for organizations striving to meet their business goals. Phase I studies usually test new ...

Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier ...